Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2011; 17(15): 1947-1960
Published online Apr 21, 2011. doi: 10.3748/wjg.v17.i15.1947
Published online Apr 21, 2011. doi: 10.3748/wjg.v17.i15.1947
- doxycycline | + 500 ng/mL doxycycline | |||||
G1-phase | G2-phase | S-phase | G1-phase | G2-phase | S-phase | |
24 h | ||||||
C35 | 34.8 ± 1.2 | 30.6 ± 5.2 | 34.7 ± 5.0 | 36.2 ± 3.2 | 27.3 ± 3.6 | 36.6 ± 1.1 |
C43 | 30.8 ± 0.9 | 29.8 ± 2.5 | 39.4 ± 3.1 | 30.7 ± 1.6 | 31.7 ± 0.9 | 37.6 ± 1.8 |
TET29 | 29.0 ± 1.7 | 38.9 ± 3.5 | 32.1 ± 2.4 | 30.2 ± 0.7 | 30.2 ± 1.5 | 39.6 ± 0.9 |
72 h | ||||||
C35 | 39.8 ± 1.1 | 24.7 ± 2.4 | 35.5 ± 2.8 | 41.1 ± 3.1 | 31.8 ± 3.6 | 27.1 ± 5.0 |
C43 | 42.6 ± 0.8 | 30.3 ± 3.5 | 27.1 ± 2.8 | 43.0 ± 4.1 | 24.0 ± 1.8 | 33.0 ± 3.0 |
TET29 | 40.4 ± 5.4 | 19.4 ± 3.7 | 40.2 ± 1.9 | 41.6 ± 4.3 | 25.9 ± 3.1 | 32.5 ± 5.6 |
- Citation: Tonack S, Patel S, Jalali M, Nedjadi T, Jenkins RE, Goldring C, Neoptolemos J, Costello E. Tetracycline-inducible protein expression in pancreatic cancer cells: Effects of CapG overexpression. World J Gastroenterol 2011; 17(15): 1947-1960
- URL: https://www.wjgnet.com/1007-9327/full/v17/i15/1947.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i15.1947